Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | -11,091 | 2,816 | 10,193 | 8,067 | 0 |
| Cost of Goods | -1,715 | 4,110 | 6,544 | 3,528 | N/A |
| Gross Profit | -9,376 | -1,294 | 3,649 | 4,539 | N/A |
| Operating Expenses | 12,331 | 89,341 | 17,038 | 18,048 | 0 |
| Operating Income | -22,422 | -90,525 | -12,845 | -12,981 | N/A |
| Other Income | -394 | -492 | -4 | 80 | 0 |
| Pre-tax Income | -22,816 | -91,017 | -12,849 | -12,901 | 0 |
| Income Tax | -37,277 | 17,608 | -11 | -12 | N/A |
| Net Income Continuous | 14,461 | -108,625 | -12,838 | -12,889 | N/A |
| Net Income Discontinuous | 9,767 | -2,291 | N/A | N/A | N/A |
| Net Income | $24,228 | $-110,916 | $-12,838 | $-12,889 | $N/A |
| EPS Basic Total Ops | -0.73 | -3.55 | -0.63 | -0.64 | N/A |
| EPS Basic Continuous Ops | -1.02 | -3.63 | -0.63 | -0.64 | N/A |
| EPS Basic Discontinuous Ops | 0.29 | 0.08 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.73 | -3.55 | -0.63 | -0.64 | N/A |
| EPS Diluted Continuous Ops | -1.02 | -3.63 | -0.63 | -0.64 | N/A |
| EPS Diluted Discontinuous Ops | 0.29 | 0.08 | N/A | N/A | N/A |
| EBITDA(a) | $-21,972 | $-89,330 | $-11,964 | $-12,145 | $N/A |